Skip to main content

Table 2 Difference in 30-day risk adjusted mortality trends between high and low Medicare share hospitals (2009–2016)

From: Association between degree of exposure to the Hospital Value Based Purchasing Program and 30-day mortality: experience from the first four years of Medicare’s pay-for-performance program

 

Average 30-day risk-adjusted mortality

High Medicare share hospitals

Low Medicare share hospitals

A. Acute myocardial infarction

 Pre-HVBP: Mean (SD)

15.9% (1.7%)

16.0% (1.8%)

 Post-HVBP: Mean SD)

14.8% (1.6%)

14.7% (1.5%)

 Pre- to Post change

−1.1%

−1.3%

 Difference-in-differences (adjusted)

0.03% (95% CI: −0.13, 0.19%)

B. Heart failure

 Pre-HVBP: Mean (SD)

11.0% (1.6%)

10.9% (1.6%)

 Post-HVBP: Mean (SD)

11.6% (1.5%)

11.4% (1.6%)

 Pre- to Post change

0.6%

0.5%

 Difference-in-differences (adjusted)

0.04% (95% CI: −0.08, 0.16)

C. Pneumonia

 Pre-HVBP: Mean (SD)

11.4% (1.9%)

11.4% (1.9%)

 Post-HVBP: Mean (SD)

11.7% (1.8%)

11.6% (1.8%)

 Pre- to Post change

0.3%

0.02%

 Difference-in-differences (adjusted)

0.11% (95% CI: −0.04, 0.27)

  1. Sources: Authors’ analysis of Hospital Compare (2009–2016), American Hospital Association Annual Survey (2009), and Final Impact Rules (2009–2016) data
  2. Observed average mortality rates reported for pre-HVBP and post-HVBP periods. Difference in average mortality rate between post- vs. pre-HVBP periods reported for high and low Medicare share hospitals based on linear random effects model regressing mortality rate on post-HVBP indicator; heteroscedasticity-robust standard errors clustered at the hospital level
  3. Difference-in-differences estimates from random effects model reported; heteroscedasticity-robust standard errors clustered at the hospital level; covariates in the model include teaching hospital status, ownership, bed size, year and region
  4. SD Standard deviation
  5. CI Confidence interval
  6. p < 0.05